期刊文献+

BRD4抑制剂JQ1对Jurkat细胞增殖抑制及凋亡诱导作用的研究 被引量:3

Effect of BRD4 Inhibitor JQl on Proliferation Inhibition and Apotosis Induction in Jurkat Cells
下载PDF
导出
摘要 目的:探讨布罗莫结构域抑制剂(JQ1)对急性T淋巴细胞白血病细胞株(Jurkat)的增殖抑制、诱导凋亡作用以及可能的作用机制。方法:应用四甲基偶氮唑蓝(MTT)法检测JQ1作用于Jurkat细胞后的细胞增殖抑制率,Annexin V-FITC/PI荧光染色流式细胞术检测细胞凋亡率的改变,实时荧光定量PCR检测Notch1及c-Myc基因表达水平。结果:随药物浓度的增加,Jurkat细胞生长受到明显抑制,表现为时间-剂量依赖性。JQ1 0.8、1.6、4μmol/L处理Jurkat细胞48和72 h后,Jurkat细胞株的凋亡率呈时间-剂量变化,与对照组比较有统计学差异(P<0.05)。PCR检测显示,药物作用48 h后Notch1及c-Myc mRNA表达均下调,与对照组相比,有显著差异。结论:JQ1可以有效抑制Jurkat细胞株的增殖,这可能是通过Notch1基因和c-Myc基因促进凋亡。JQ1可以作为治疗T-ALL新途径之一。 Objective:To investigate the effect and possible mechanism of bromo-domain inhibitors(JQ1) on proliferation inhibition and inducing apoptosis of acute T lymphocyte leukemia cell line(Jurkat).Methods:Jurkat cell line was treated by JQ1 at different concentrations.MTT was used to detect the cell proliferation inhibition rate.The flow cytometry with AnnexinV-FITC/PI fluorescence staining was used to detect the changes of apoptosis rate,and realtime fluorescent quantitative PCR was used to detect c-Myc/Notchl gene expression levels.Results:With the increasing of drug concentration and prolonging of time,the inhibitory rate of Jurkat cell growth was enhanced in time-dose dependent manner;Jurkat cells was treated by 0.8,1.6,and 4 μ mol/LJQ1 for 48 h and 72 h,the cell apoptosis rate was enhanced with the increase of drug concentration and prolonging of time,and the difference was statistically different in comparison with the control group(P < 0.05);PCR detection indicated that Notchl and c-Myc mRNA expression was reduced in 48 h after JQ1 treatment,which was statistically different from the control group,(P < 0.05).Conclusion:JQ1 can effectively inhibit the growth of Jurkat cell line,and potentially induce apoptosis through Notchl and c-Myc gene.Hence JQ1 may be one of new methods used to treat T-ALL.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2016年第4期1019-1023,共5页 Journal of Experimental Hematology
关键词 JQ1 Notch1/c-Myc JURKAT细胞 细胞凋亡 JQ1 Notch1/c-Myc Jurkat cell apoptosis
  • 相关文献

参考文献11

  • 1Yetil A,B Anchang,AM Gouw,SJ Adam,T Zabuawala,R Parameswaran,J van Riggelen,S Plevritis,DW Felsher.p19ARF is a critical mediator of both cellular senescence and an innate immune response associated with MYCinactivation in mouse model of acute leukemia. Oncotarget . 2015
  • 2Baratta MG,Schinzel AC,Zwang Y,et al.An in-tumor genetic screen reveals that the BET bromodomain protein,BRD4,is a potential therapeutic target in ovarian carcinoma. Proceedings of the National Academy of Sciences of the United States of America . 2015
  • 3Kandela I,Jin HY,Owen K,et al.Registered report:BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Elife . 2015
  • 4Yashiro-Ohtani Y,Wang H,Zang C,et al.Long-range enhancer activity determines Myc sensitivity to Notch1 inhibitors in T cell leukemia. Proceedings of the National Academy of Sciences of the United States of America . 2014
  • 5Qin Feng,Zheng Zhang,Martin J Shea,Chad J Creighton,Cristian Coarfa,Susan G Hilsenbeck,Rainer Lanz,Bin He,Lei Wang,Xiaoyong Fu,Agostina Nardone,Yongcheng Song,James Bradner,Nicholas Mitsiades,Constantine S Mitsiades,C Kent Osborne,Rachel Schiff,Bert W O'Malley.An epigenomic approach to therapy for tamoxifen-resistant breast cancer[J].Cell Research,2014,24(7):809-819. 被引量:11
  • 6Sharma Vishva Mitra,Calvo Jennifer A,Draheim Kyle M,Cunningham Leslie A,Hermance Nicole,Beverly Levi,Krishnamoorthy Veena,Bhasin Manoj,Capobianco Anthony J,Kelliher Michelle A.Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc. Molecular and Cellular Probes . 2006
  • 7Demarest Renée M,Dahmane Nadia,Capobianco Anthony J.Notch is oncogenic dominant in T-cell acute lymphoblastic leukemia. Blood . 2011
  • 8Choi Peter S,van Riggelen Jan,Gentles Andrew J,Bachireddy Pavan,Rakhra Kavya,Adam Stacey J,Plevritis Sylvia K,Felsher Dean W.Lymphomas that recur after MYC suppression continue to exhibit oncogene addiction. Proceedings of the National Academy of Sciences of the United States of America . 2011
  • 9Knoechel B,Roderick JE,Williamson KE,et al.An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia. Nature Genetics . 2014
  • 10Roderick JE,Tesell J,Shultz LD,et al.c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells. Blood . 2014

二级参考文献13

  • 1Winter GE, Rix U, Carlson SM, et al. System-pharmacology dissec- tion of drug synergy in imatinib-resistant CML. Nature Chemical Biolo- gy,2012 ;8( 11 ) :905 -912.
  • 2Couban S, Savoie L. Evidence-based guidelines for the use of ty- rosinekinase inhibitors in adultswithPhiladelphia chromosome-positive or BCR-ABL positive acute lymphoblastic leukemia: a Canadian con- sensus. Cur Oncol,2014 ;21 ( 2 ) :265 - 309.
  • 3Dang CV. MYC on the path to Cancer. Cell; 2012; 149(3) :22 - 35.
  • 4Ito T, Kwon HY, Zimdahl B, et al. Regulation of myeloid leukaemia by the cell-fate determinant Musashi. Nature, 2010;7 (21) :765 - 768.
  • 5Danika Di Giacomo, Valentina Pierini, Gianluca Barba, et al. Blast crisis Ph^+ chronic myeloid leukemia with NUP98/HOXA13 up-regu- lating MSI2. Molecular Cytogenetics, 2014 ;7 (20) :42 - 48.
  • 6Kharas MG, Lengner CJ, AL-Shahrour F, et al. Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia. Nat Med,2010;9(16) :903 -908.
  • 7邹秀平,黄伟,刘珊珊,徐艳玲.MSI2和Numb在白血病中的表达及分析[J].临床血液学杂志,2013,26(3):319-321. 被引量:2
  • 8朱雨,潘良琴,钱思轩,宋萍,于慧,张苏江,葛峥,洪鸣,田甜,李建勇.达沙替尼治疗伊马替尼耐药的BCR/ABL阳性白血病的临床研究[J].中国实验血液学杂志,2013,21(3):581-586. 被引量:18
  • 9刘霆.TKI时代Ph阳性急性淋巴细胞白血病的治疗[J].临床血液学杂志,2013,26(6):754-757. 被引量:2
  • 10林忠琨,张闰,葛峥,刘娟,郭星,乔纯,吴雨洁,仇海荣,张建富,李建勇.成人T细胞急性淋巴细胞白血病中NOTCH1突变的特征研究[J].中国实验血液学杂志,2013,21(6):1403-1408. 被引量:9

共引文献11

同被引文献31

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部